L150-0951 Screening compound: butyl 3-{[4-(morpholin-4-yl)phenyl]amino}quinoxaline-2-carboxylate

L150-0951 Screening compound: butyl 3-{[4-(morpholin-4-yl)phenyl]amino}quinoxaline-2-carboxylate
L150-0951 Screening compound: butyl 3-{[4-(morpholin-4-yl)phenyl]amino}quinoxaline-2-carboxylate alternative view

Chemical Structure Depiction of ChemDiv screening compound L150-0951
butyl 3-{[4-(morpholin-4-yl)phenyl]amino}quinoxaline-2-carboxylate

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L150-0951

Molecular Formula

C23H26N4O3 (C23 H26 N4 O3)

Compound Name

butyl 3-{[4-(morpholin-4-yl)phenyl]amino}quinoxaline-2-carboxylate

IUPAC name

butyl 3-{[4-(morpholin-4-yl)phenyl]amino}quinoxaline-2-carboxylate

SMILES

CCCCOC(c1nc2ccccc2nc1Nc(cc1)ccc1N1CCOCC1)=O

InChI

InChI=1S/C23H26N4O3/c1-2-3-14-30-23(28)21-22(26-20-7-5-4-6-19(20)25-21)24-17-8-10-18(11-9-17)27-12-15-29-16-13-27/h4-11H,2-3,12-16H2,1H3,(H,24,26)

InChI Key

XXBLVYNUEWQSPO-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27234515

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

406.48

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.590

Distribution Coefficient, logD

4.590

Water Solubility, LogSw

-4.20

Polar Surface Area

59.903

Acid Dissociation Constant (pKa)

15.83

Base Dissociation Constant (pKb)

7.17

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

34.80

L150-0951 in Drug Discovery

Included in Screening Libraries

Arginase Targeted Library (2009 compounds)

PI3K-Targeted Library (17255 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Akt-Targeted Library (14764 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Male
  • Cardiovascular
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Others
  • Kinases
  • GPCR
  • Kinases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with L150-0951 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L150-0951?
Check Price and Availability of L150-0951, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L150-0951 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L150-0951
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L150-0951
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L150-0951 available by request